Photo of Erman Akkus taken from mn.uio.no
Mar 3, 2024, 01:59
Erman Akkus: Does primary tumor resection prolong OS in inoperable synchronous metastatic CRC?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X:
“Does primary tumor resection (PTR) prolong (OS) in inoperable synchronous metastatic CRC? SYNCHRONOUS and CCRe-IV trials Journal of Clinical Oncology.
Negative study
- Patients with tumor-related symptoms or diagnostic findings requiring primary surgery (eg, lower GI bleeding requiring transfusion, bowel obstruction, tumor perforation, or intractable pain) excluded.
- PTR vs no PTR, OS: 16.7 months (95% CI, 13.2 to 19.2) vs 18.6 months (16.2 to 22.3) (P = .191).
- Serious adverse events more common in No PTR (10.2% vs 18.0%; P = .027)”
Read further.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54